High circulating CD3+CD56+CD16+ natural killer-like T cell levels predict a better IVF treatment outcome

Journal of Reproductive Immunology

Volumn 97, Issue 2, 2013, Pages 197-203

  Zhou, Jianjun ^a,b   Zhao, Xia ^b   Wang, Zhiqun ^b   Wang, Junxia ^b   Sun, Haixiang ^b   Hu, Yali ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

CD16; CD3; CD56; IVF; Natural killer like T cell

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; LIVE BIRTH; MAJOR CLINICAL STUDY; NATURAL KILLER T CELL; OOCYTE RETRIEVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD3; ANTIGENS, CD56; BIRTH RATE; CHEMOKINE CCL2; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LYMPHOCYTE COUNT; NATURAL KILLER T-CELLS; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; RECEPTORS, IGG; RNA, MESSENGER; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875265022     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.12.006     Document Type: Article

References (38)

1. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
2. Bojarska-Junak A., Hus I., Sieklucka M., Wasik-Szczepanek E., Mazurkiewicz T., Polak P., Dmoszynska A., Rolinski J. Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome. Oncol. Rep. 2010, 24:803-810.
3. Boyson J.E., Rybalov B., Koopman L.A., Exley M., Balk S.P., Racke F.K., Schatz F., Masch R., Wilson S.B., Strominger J.L. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13741-13746.
4. Boyson J.E., Aktan I., Barkhuff D.A., Chant A. NKT cells at the maternal-fetal interface. Immunol. Invest. 2008, 37:565-582.
5. Dekel N., Gnainsky Y., Granot I., Mor G. Inflammation and implantation. Am. J. Reprod. Immunol. 2010, 63:17-21.
6. Geiben-Lynn R., Greenland J.R., Frimpong-Boateng K., Letvin N.L. Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d. J. Biol. Chem. 2009, 284:33800-33806.
7. Giuliani A., Schoell W., Auner J., Urdl W. Controlled ovarian hyperstimulation in assisted reproduction: effect on the immune system. Fertil. Steril. 1998, 70:831-835.
8. Gnainsky Y., Granot I., Aldo P.B., Barash A., Or Y., Schechtman E., Mor G., Dekel N. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil. Steril. 2010, 94:2030-2036.
9. Guerin L.R., Prins J.R., Robertson S.A. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?. Hum. Reprod. Update 2009, 15:517-535.
10. Guleria I., Pollard J.W. The trophoblast is a component of the innate immune system during pregnancy. Nat. Med. 2000, 6:589-593.
11. Hodge G., Hodge S., Li-Liew C., Reynolds P.N., Holmes M. Increased natural killer T-like cells are a major source of pro-inflammatory cytokines and granzymes in lung transplant recipients. Respirology 2012, 17:155-163.
12. Jianjun Z., Yali H., Zhiqun W., Mingming Z., Xia Z. Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia. Am. J. Reprod. Immunol. 2010, 63:38-45.
13. Kheshtchin N., Gharagozloo M., Andalib A., Ghahiri A., Maracy M.R., Rezaei A. The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy. Am. J. Reprod. Immunol. 2010, 64:104-112.
14. Khvedelidze M., Chkhartishvili N., Abashidze L., Dzigua L., Tsertsvadze T. Expansion of CD3/CD16/CD56 positive NKT cells in HIV/AIDS: the pilot study. Georgian Med. News 2008, 165:78-83.
15. Lee J.Y., Lee M., Lee S.K. Role of endometrial immune cells in implantation. Clin. Exp. Reprod. Med. 2011, 38:119-125.
16. Mehta B.A., Schmidt-Wolf I.G., Weissman I.L., Negrin R.S. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. Blood 1995, 86:3493-3499.
17. Molling J.W., Moreno M., van der Vliet H.J., van den Eertwegh A.J., Scheper R.J., von Blomberg B.M., Bontkes H.J. Invariant natural killer T cells and immunotherapy of cancer. Clin. Immunol. 2008, 129:182-194.
18. Mor G., Cardenas I., Abrahams V., Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann. N. Y. Acad. Sci. 2011, 1221:80-87.
19. Noronha L.E., Antczak D.F. Maternal immune responses to trophoblast: the contribution of the horse to pregnancy immunology. Am. J. Reprod. Immunol. 2010, 64:231-244.
20. Norris S., Doherty D.G., Collins C., McEntee G., Traynor O., Hegarty J.E., O'Farrelly C. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum. Immunol. 1999, 60:20-31.
21. Pazos M., Sperling R.S., Moran T.M., Kraus T.A. The influence of pregnancy on systemic immunity. Immunol. Res. 2012, 54:254-261.
22. Pilla L., Squarcina P., Coppa J., Mazzaferro V., Huber V., Pende D., Maccalli C., Sovena G., Mariani L., Castelli C., Parmiani G., Rivoltini L. Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. Cancer 2005, 65:3942-3949.
23. Pratschke J., Stauch D., Kotsch K. Role of NK and NKT cells in solid organ transplantation. Transpl. Int. 2009, 2009:859-868.
24. Saito S., Nakashima A., Shima T., Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 2010, 63:601-610.
25. Szekeres-Bartho J., Wegmann T.G. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol. 1996, 31:81-95.
26. Thum M.Y., Bhaskaran S., Abdalla H.I., Ford B., Sumar N., Shehata H., Bansal A.S. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum. Reprod. 2004, 19:2395-2400.
27. Tilburgs T., Roelen D.L., van der Mast B.J., de Groot-Swings G.M., Kleijburg C., Scherjon S.A., Claas F.H. Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the deciduas in human pregnancy. J. Immunol. 2008, 180:5737-5745.
28. Uemura Y., Suzuki M., Liu T.Y., Narita Y., Hirata S., Ohyama H., Ishihara O., Matsushita S. Role of human non-invariant NKT lymphocytes in the maintenance of type 2 T helper environment during pregnancy. Int. Immunol. 2008, 20:405-412.
29. Vallejo A.N., Hamel D.L., Mueller R.G., Ives D.G., Michel J.J., Boudreau R.M., Newman A.B. NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging. PLoS One 2011, 6:e26558.
30. van den Heuvel M.J., Peralta C.G., Hatta K., Han V.K., Clark D.A. Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am. J. Reprod. Immunol. 2007, 58:447-459.
31. van den Heuvel M.J., Hatta K., Peralta C.G., Han V.K., Clark D.A. CD56+ cells are recruited to the uterus in two waves: at ovulation and during the first 2 weeks after missed menses. Am. J. Reprod. Immunol. 2008, 59:90-98.
32. Van Kaer L. Natural killer T cells as targets for immunotherapy of autoimmune diseases. Immunol. Cell Biol. 2004, 82:315-322.
33. von Rango U. Fetal tolerance in human pregnancy - a crucial balance between acceptance and limitation of trophoblast invasion. Immunol. Lett. 2008, 115:21-32.
34. Warning J.C., McCracken S.A., Morris J.M. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 2011, 141:715-724.
35. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol. Today 1993, 14:353-356.
36. Williams P.J., Searle R.F., Robson S.C., Innes B.A., Bulmer J.N. Decidual leucocyte populations in early to late gestation normal human pregnancy. J. Reprod. Immunol. 2009, 82:24-31.
37. Yamada H., Morikawa M., Kato E.H., Shimada S., Kobashi G., Minakami H. Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am. J. Reprod. Immunol. 2003, 50:351-354.
38. Zhou J., Wang Z., Zhao X., Wang J., Sun H., Hu Y. An increase of Treg cells in the peripheral blood is associated with a better in vitro fertilization treatment outcome. Am. J. Reprod. Immunol. 2012, 68:100-106.